Stock Events

Stock Events

Claritas Pharmaceuticals 

$0
2
+$0+0% Friday 21:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
250
Avg. Volume
0
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Profitable
2015
2016
2017
2018
2019
2020
0Revenue
8.42MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLAZF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a major player in the pharmaceutical industry, developing drugs that can compete directly with Claritas Pharmaceuticals' offerings.
Merck
MRK
Mkt Cap214.76B
Merck produces a wide range of pharmaceutical products that could compete in the same therapeutic areas as Claritas Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division, develops medications that may overlap with the treatments offered by Claritas Pharmaceuticals.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline focuses on a broad portfolio of drugs, potentially competing in the same niche as Claritas Pharmaceuticals.
Novartis
NVS
Mkt Cap237.61B
Novartis is known for its innovative medicines and could have competing products in the same categories as Claritas Pharmaceuticals.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in similar therapeutic areas and could have drugs that compete with those of Claritas Pharmaceuticals.
AMGEN
AMGN
Mkt Cap160.66B
Amgen, a biotech firm, develops therapies that might directly compete with Claritas Pharmaceuticals' biopharmaceutical products.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb offers a range of prescription medicines that could directly compete with Claritas Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company develops drugs that could be in direct competition with the treatments developed by Claritas Pharmaceuticals.
Sanofi
SNY
Mkt Cap124.45B
Sanofi produces a variety of pharmaceutical products that could compete across several of the same therapeutic areas as Claritas Pharmaceuticals.

About

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.
Show more...
CEO
Mr. Robert Farrell J.D.
Country
US
ISIN
CA1806342061

Listings

OTC Link
US
CLAZF

0 Comments

Share your thoughts

FAQ

What is Claritas Pharmaceuticals stock price today?▼
The current price of CLAZF is $0 USD — it has increased by +0% in the past 24 hours. Watch Claritas Pharmaceuticals stock price performance more closely on the chart.
What is Claritas Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Claritas Pharmaceuticals stocks are traded under the ticker CLAZF.
Is Claritas Pharmaceuticals stock price growing?▼
CLAZF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Claritas Pharmaceuticals has showed a +0% increase.
When is the next Claritas Pharmaceuticals earnings date?▼
Claritas Pharmaceuticals is going to release the next earnings report on May 29, 2026.
What is Claritas Pharmaceuticals revenue for the last year?▼
Claritas Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Claritas Pharmaceuticals net income for the last year?▼
CLAZF net income for the last year is 8.42M USD.
In which sector is Claritas Pharmaceuticals located?▼
Claritas Pharmaceuticals operates in the Health Care sector.
When did Claritas Pharmaceuticals complete a stock split?▼
The last stock split for Claritas Pharmaceuticals was on July 23, 2021 with a ratio of 1:20.
Where is Claritas Pharmaceuticals headquartered?▼
Claritas Pharmaceuticals is headquartered in San Rafael, US.